A broth dilution assay was used to determine the in vitro susceptibilities of 10 ocular isolates of Bacillus cereus to clindamycin, gentamicin, and vancomycin both alone and in combination. The checkerboard technique was used to determine fractional inhibitory and bactericidal concentration indices for combinations of clindamycin-gentamicin and vancomycin-gentamicin.
Bacillus cereus has emerged as one of the most virulent bacteria to affect the eye, causing a destructive endophthalmitis following trauma or intravenous drug use (1, 2, 5, 8-10, 14-17, 21) . Nevertheless, there is limited information available with respect to its antimicrobial agent susceptibility. Published data suggest that B. cereus isolates are susceptible in vitro to gentamicin, vancomycin, clindamycin, chloramphenicol, and erythromycin (1, 4, 12, 14, 17, 20) . The purpose of the present study was to investigate the in vitro antimicrobial agent susceptibility of 10 ocular isolates of B. cereus. A checkerboard technique was used to assess the effects of clindamycin, gentamicin, and vancomycin, used both alone and in combination.
The microorganisms studied were 10 B. cereus isolates recovered from ocular tissue specimens submitted to the Sid W. Richardson Ocular Microbiology Laboratory. Five isolates were recovered from vitreous, two isolates were recovered from corneal tissue, and three isolates were recovered from lids and orbital tissues. The isolates were identified by using the Minitek system.
The antibiotics used were clindamycin hydrochloride, gentamicin sulfate, and vancomycin hydrochloride. These antibiotics were selected because of their activities against B. cereus as suggested by previous reports and because they are commonly used against serious ocular infections (3, 14, 20 (14) reported on six clinical B. cereus isolates, but they reported only mean susceptibility data and failed to include a description of their laboratory methods. Weber et al. (20) reported on the in vitro susceptibility of 54 clinical isolates of B. cereus to selected antimicrobial agents. Susceptibility testing was performed by both broth microdilution assay and disk diffusion testing, with values limited to single-agent inhibitory activity.
O'Day et al. (14) also suggested that the combination of clindamycin and gentamicin was synergistic in the treatment of B. cereus. This assumption was based on the clinical microbiologic success of combined therapy in an experimental rabbit model of endophthalmitis. This was not confirmed by fractional concentration indices or isobolograms.
According to the in vitro data for ocular isolates contained in this report, clindamycin, vancomycin, and gentamicin are all relatively effective single agents against B. cereus. Additionally, the combinations of clindamycin-gentamicin and vancomycin-gentamicin are synergistic or near synergistic for most B. cereus isolates. Clindamycin-gentamicin demonstrated bactericidal synergy for slightly higher number of B. cereus isolates than vancomycin-gentamicin did. This bactericidal effect may be important clinically in disease states such as endophthalmitis, in which the host immune response to infection results in end organ damage, and in immunocompromised hosts, who have been shown to be at risk of developing B. cereus infections (4, 7, 10, 12) .
